Source: Genome Medicine: medicine in the post-genomic era. Unidade: ICB
Subjects: PARASITOLOGIA, PLASMODIUM FALCIPARUM, INFECÇÕES POR PROTOZOÁRIOS, VACINAS, MALÁRIA, GENOMAS, EPITOPOS, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSER, Kara A. et al. Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential. Genome Medicine: medicine in the post-genomic era, v. 12, n. 1, p. 17 , 2020Tradução . . Disponível em: https://doi.org/10.1186/s13073-019-0708-9. Acesso em: 01 nov. 2024.APA
Moser, K. A., Drábek, E. F., Dwivedi, A., Stucke, E. M., Crabtree, J., Dara, A., et al. (2020). Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential. Genome Medicine: medicine in the post-genomic era, 12( 1), 17 . doi:10.1186/s13073-019-0708-9NLM
Moser KA, Drábek EF, Dwivedi A, Stucke EM, Crabtree J, Dara A, Shah Z, Adams M, Li T, Rodrigues PT, Koren S, Phillipy AM, Munro JB, Ouattara A, Sparklin BC, Hotopp JCD, Lyke KE, Sadzewicz L, Tallon LJ, Spring MD, Jongsakul K, Lon C, Saunders DL, Ferreira MU, Nyunt MM, Laufer MK, Travassos MA, Sauerwein RW, Harrison ST, Fraser CM, Sim BKL, Hoffman SL, Plowe C, Silva JC. Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential [Internet]. Genome Medicine: medicine in the post-genomic era. 2020 ; 12( 1): 17 .[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s13073-019-0708-9Vancouver
Moser KA, Drábek EF, Dwivedi A, Stucke EM, Crabtree J, Dara A, Shah Z, Adams M, Li T, Rodrigues PT, Koren S, Phillipy AM, Munro JB, Ouattara A, Sparklin BC, Hotopp JCD, Lyke KE, Sadzewicz L, Tallon LJ, Spring MD, Jongsakul K, Lon C, Saunders DL, Ferreira MU, Nyunt MM, Laufer MK, Travassos MA, Sauerwein RW, Harrison ST, Fraser CM, Sim BKL, Hoffman SL, Plowe C, Silva JC. Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential [Internet]. Genome Medicine: medicine in the post-genomic era. 2020 ; 12( 1): 17 .[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s13073-019-0708-9